- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06703424
Effects of Light Intensity Physical Activities on Pre-frontal Cortical Activation, Cognitive Function, Sleepiness and Back Pain
April 13, 2026 updated by: Chia Yong Hwa Michael
Investigating the Acute Effects of Light Intensity Physical Activities on Pre-frontal Cortical Activation, Cognitive Function, Sleepiness and Back Pain Among Physically Inactive University Students
The objective of this randomised controlled trial is to examine the acute effects of two novel light intensity exercise (sit-cycling and stand-twisting) on prefrontal cortical blood oxygenation, executive functioning, sleepiness and back pain among inactive university students.
The main questions it aims to answer are:
- What are the changes in oxygenated haemoglobin (O2Hb) and deoxygenated hemoglobin (HHb) levels in the prefrontal cortex from baseline to immediately after and 20 minutes after a 5-min bout of S-C and S-T compared to sitting for the same duration?
- What are the changes in executive functioning, specifically, n-back test and Word Colour Stroop test performance from baseline to immediately after and 20 minutes after a bout of S-C and S-T compared to sitting for the same duration?
- How does participants' self-rated daytime sleepiness and back pain after a bout of S-C and S-T compare to sitting for the same duration?
Participants will:
- Perform sit-cycling or stand-twisting for 5 mins (experimental condition) and sit for 5 mins (control condition)
- Wear the functional near-infrared spectroscopy cap on their head throughout the measurements
- Complete 1-back, 2-back test and Word Colour Stroop before, immediately after and 20 minutes after experimental/ control condition
- Have their blood pressure, heart rate taken by a smartwatch
- Complete a daytime sleepiness questionnaire and a back pain questionnaire
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Singapore
-
Singapore, Singapore, Singapore
- Block 5 Physical Education and Sport Science
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- NTU-NIE university student, between 21 and 30 years old, do not meet physical activity guidelines (150 mins of weekly MVPA)
Exclusion Criteria:
- taking blood-pressure lowering medication
- physically active (150 mins or more of weekly MVPA)
- deemed not physically fit to participate in physical activity based on responses to Get Active Questionnaire
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Sit-cycling
Sit-cycling on a seat-cycle for 5 mins
|
Sit-cycling for 5 mins
|
|
Experimental: Stand-twisting
Stand-twisting on a stand-twister for 5 mins
|
Stand-twisting for 5 mins
|
|
No Intervention: Sitting only
Sitting only for 5 mins
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
1-back test accuracy (%)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
Number of correct trials (correct recall)
|
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
|
1-back test reaction time (ms)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
Average reaction time across trials
|
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
|
2-back test accuracy (%)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
Number of correct trials (correct recall)
|
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
|
2-back test reaction time (ms)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
Average reaction time across trials
|
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
|
Colour Word Stroop test accuracy (congruent) (%)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
Number of correct trials recall
|
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
|
Colour Word Stroop test accuracy (incongruent) (%)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
Number of correct trials recall
|
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
|
Colour Word Stroop test reaction time (congruent) (ms)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
Average reaction time across trials
|
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
|
Colour Word Stroop test reaction time (incongruent) (ms)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
Average reaction time across trials
|
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
|
pre-frontal cortical oxygenated hemoglobin levels (micrometre)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
measured by functional near infrared spectroscopy
|
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
|
pre-frontal cortical deoxygenated hemoglobin levels (micrometre)
Time Frame: Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
measured by functional near infrared spectroscopy
|
Pretest, post-test 1 (immediately after experimental condition) and post-test 2 (after post-test 1)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 11, 2024
Primary Completion (Actual)
December 31, 2024
Study Completion (Actual)
December 31, 2024
Study Registration Dates
First Submitted
November 21, 2024
First Submitted That Met QC Criteria
November 21, 2024
First Posted (Actual)
November 25, 2024
Study Record Updates
Last Update Posted (Actual)
April 16, 2026
Last Update Submitted That Met QC Criteria
April 13, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NanyangTU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data constitute as personal data.
Under the Singapore Personal Data Protection Act, it is mandatory that individually identifiable data are to be kept confidential.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sit-cycling
-
Beijing Sport UniversityCompleted
-
Unidad Enfermedades Cardiometabolicas- Hospital...Recruiting
-
George Fox UniversityRecruitingCan BFR Cycling Augment Strength and VO2peakUnited States
-
Verein zur Förderung der Rehabilitationsforschung...Deutsche Arthrose-Hilfe; Verein zur Förderung der Erforschung und Bekämpfung... and other collaboratorsCompleted
-
University of VigoCompleted
-
VA Office of Research and DevelopmentRecruitingParkinson's DiseaseUnited States
-
Western University, CanadaCompleted
-
Chang Gung Memorial HospitalRecruitingEccentric Exercise TrainingTaiwan
-
Chang Gung Memorial HospitalCompletedEccentric Exercise TrainingTaiwan
-
Universiti Tunku Abdul RahmanCompletedOverweight and ObesityMalaysia